- Home
- NBTX vs EXPI Comparison
NBTX vs EXPI Comparison
Compare NBTX & EXPI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NBTX | EXPI |
|---|---|---|
| Founded | 2003 | 2008 |
| Country | France | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.0B |
| IPO Year | 2018 | 2010 |
Fundamental Metrics
Financial Performance| Metric | NBTX | EXPI |
|---|---|---|
| Price | $45.00 | $6.76 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | ★ $36.00 | $9.75 |
| AVG Volume (30 Days) | 56.8K | ★ 798.2K |
| Earning Date | 03-31-2026 | 05-11-2026 |
| Dividend Yield | N/A | ★ 3.18% |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $500,147,681.00 |
| Revenue This Year | $58.17 | $6.26 |
| Revenue Next Year | N/A | $5.50 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 220.39 |
| 52 Week Low | $3.64 | $5.66 |
| 52 Week High | $44.46 | $12.23 |
Technical Indicators
Market Signals| Indicator | NBTX | EXPI |
|---|---|---|
| Relative Strength Index (RSI) | 72.20 | 60.03 |
| Support Level | $20.11 | $5.68 |
| Resistance Level | N/A | $6.87 |
| Average True Range (ATR) | 2.08 | 0.23 |
| MACD | 1.20 | 0.04 |
| Stochastic Oscillator | 99.80 | 81.56 |
Price Performance
Historical ComparisonAbout NBTX Nanobiotix S.A.
Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.
About EXPI eXp World Holdings Inc.
eXp World Holdings Inc is a cloud-based residential real estate company. The company owns and operates a cloud-based real estate brokerage and a technology platform business that develops and uses immersive technologies that help businesses increase their effectiveness and reduce costs from operating in traditional brick-and-mortar office spaces. Its business categories include Real Estate Brokerage, Technology Products and Services, Title, Escrow, Settlement Services, and Mortgage Brokerage Services.